An Overview of APP Processing Enzymes and Products
10.1007/s12017-009-8104-z
Crossref journal-article
Springer Science and Business Media LLC
NeuroMolecular Medicine (297)
Authors 4
  1. Vivian W. Chow (first)
  2. Mark P. Mattson (additional)
  3. Philip C. Wong (additional)
  4. Marc Gleichmann (additional)
References 113 Referenced 536
  1. Abad-Rodriguez, J., Ledesma, M. D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., et al. (2004). Neuronal membrane cholesterol loss enhances amyloid peptide generation. Journal of Cell Biology, 167, 953–960. (10.1083/jcb.200404149) / Journal of Cell Biology by J Abad-Rodriguez (2004)
  2. Asai, M., Hattori, C., Szabó, B., Sasagawa, N., Maruyama, K., Tanuma, S., et al. (2003). Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochemical and Biophysical Research Communications, 301, 231–235. (10.1016/S0006-291X(02)02999-6) / Biochemical and Biophysical Research Communications by M Asai (2003)
  3. Baier, M., Apelt, J., Riemer, C., Gültner, S., Schwarz, A., Bamme, T., et al. (2008). Prion infection of mice transgenic for human APPSwe: Increased accumulation of cortical formic acid extractable Abeta(1–42) and rapid scrapie disease development. International Journal of Developmental Neuroscience, 26, 821–824. (10.1016/j.ijdevneu.2008.07.001) / International Journal of Developmental Neuroscience by M Baier (2008)
  4. Beel, A. J., & Sanders, C. R. (2008). Substrate specificity of gamma-secretase and other intramembrane proteases. Cellular and Molecular Life Sciences, 65, 1134–1311. / Cellular and Molecular Life Sciences by AJ Beel (2008)
  5. Böhme, L., Hoffmann, T., Manhart, S., Wolf, R., & Demuth, H. U. (2008). Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases. Biological chemistry, 389, 1055–1066. (10.1515/BC.2008.125) / Biological chemistry by L Böhme (2008)
  6. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., et al. (2001). BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nature Neuroscience, 4, 233–234. (10.1038/85064) / Nature Neuroscience by H Cai (2001)
  7. Caillé, I., Allinquant, B., Dupont, E., Bouillot, C., Langer, A., Müller, U., et al. (2004). Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development, 131, 2173–2181. (10.1242/dev.01103) / Development by I Caillé (2004)
  8. Chan, S. L., Mayne, M., Holden, C. P., Geiger, J. D., & Mattson, M. P. (2000). Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. The Journal of Biological Chemistry, 275, 18195–18200. (10.1074/jbc.M000040200) / The Journal of Biological Chemistry by SL Chan (2000)
  9. Cheng, H., Vetrivel, K. S., Gong, P., Meckler, X., Parent, A., & Thinakaran, G. (2007). Mechanisms of disease: new therapeutic strategies for Alzheimer’s disease–targeting APP processing in lipid rafts. Nature Clinical Practice. Neurology, 3, 374–382. (10.1038/ncpneuro0549) / Nature Clinical Practice. Neurology by H Cheng (2007)
  10. Cheung, K. H., Shineman, D., Müller, M., Cárdenas, C., Mei, L., Yang, J., et al. (2008). Mechanism of Ca2+ disruption in Alzheimer’s disease by presenilin regulation of InsP3 receptor channel gating. Neuron, 58, 871–883. (10.1016/j.neuron.2008.04.015) / Neuron by KH Cheung (2008)
  11. Clement, A. B., Hanstein, R., Schröder, A., Nagel, H., Endres, K., Fahrenholz, F., et al. (2008). Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience, 152, 459–468. (10.1016/j.neuroscience.2007.10.060) / Neuroscience by AB Clement (2008)
  12. Cole, D. C., Stock, J. R., Kreft, A. F., Antane, M., Aschmies, S. H., Atchison, K. P., et al. (2009). (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta, beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor. Bioorganic and Medicinal Chemistry Letters, 19, 926–929. (10.1016/j.bmcl.2008.11.116) / Bioorganic and Medicinal Chemistry Letters by DC Cole (2009)
  13. Cole, S. L., & Vassar, R. (2008). The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. The Journal of Biological Chemistry, 283, 29621–29625. (10.1074/jbc.R800015200) / The Journal of Biological Chemistry by SL Cole (2008)
  14. De Strooper, B., & Annaert, W. (2000). Proteolytic processing and cell biological functions of the amyloid precursor protein. Journal of Cell Science, 113, 1857–1870. (10.1242/jcs.113.11.1857) / Journal of Cell Science by B Strooper De (2000)
  15. Edwards, D. R., Handsley, M. M., & Pennington, C. J. (2008). The ADAM metalloproteinases. Molecular Aspects of Medicine, 29, 258–289. (10.1016/j.mam.2008.08.001) / Molecular Aspects of Medicine by DR Edwards (2008)
  16. Fahrenholz, F., Gilbert, S., Kojro, E., Lammich, S., & Postina, R. (2000). Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Annals of the New York Academy of Sciences, 920, 215–222. (10.1111/j.1749-6632.2000.tb06925.x) / Annals of the New York Academy of Sciences by F Fahrenholz (2000)
  17. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., & Choe, H. (2000). BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proceedings of the National Academy of Sciences of the United States of America, 97, 9712–9717. (10.1073/pnas.160115697) / Proceedings of the National Academy of Sciences of the United States of America by M Farzan (2000)
  18. Furukawa, K., Barger, S. W., Blalock, E. M., & Mattson, M. P. (1996). Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature, 379, 74–78. (10.1038/379074a0) / Nature by K Furukawa (1996)
  19. Gakhar-Koppole, N., Hundeshagen, P., Mandl, C., Weyer, S. W., Allinquant, B., Müller, U., et al. (2008). Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway. European Journal of Neuroscience, 28, 871–882. (10.1111/j.1460-9568.2008.06398.x) / European Journal of Neuroscience by N Gakhar-Koppole (2008)
  20. Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T. & Pimplikar, S. W. (2009). Alzheimer’s disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proceedings of the National Academy of Sciences of the United States of America (in press). (10.1073/pnas.0907652106)
  21. Gómez-Ramos, P., & Asunción Morán, M. (2007). Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains. Journal of Alzheimer’s Disease, 11, 53–59. (10.3233/JAD-2007-11109) / Journal of Alzheimer’s Disease by P Gómez-Ramos (2007)
  22. Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., et al. (2009). The up-regulation of BACE1 mediated by hypoxia and ischemic injury: Role of oxidative stress and HIF1alpha. Journal of Neurochemistry, 108, 1045–1056. (10.1111/j.1471-4159.2008.05858.x) / Journal of Neurochemistry by M Guglielmotto (2009)
  23. Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin, G. M., et al. (1997). Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. Journal of Neuroscience, 17, 4212–4222. (10.1523/JNEUROSCI.17-11-04212.1997) / Journal of Neuroscience by Q Guo (1997)
  24. Herzog, V., Kirfel, G., Siemes, C., & Schmitz, A. (2004). Biological roles of APP in the epidermis. European Journal of Cell Biology, 83, 613–624. (10.1078/0171-9335-00401) / European Journal of Cell Biology by V Herzog (2004)
  25. Hirata-Fukae, C., Sidahmed, E. H., Gooskens, T. P., Aisen, P. S., Dewachter, I., Devijver, H., et al. (2008). Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo. Neuroscience Letters, 435, 186–189. (10.1016/j.neulet.2008.02.032) / Neuroscience Letters by C Hirata-Fukae (2008)
  26. Hoey, S. E., Williams, R. J., & Perkinton, M. S. (2009). Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. Journal of Neuroscience, 29, 4442–4460. (10.1523/JNEUROSCI.6017-08.2009) / Journal of Neuroscience by SE Hoey (2009)
  27. Hoffmann, J., Twiesselmann, C., Kummer, M. P., Romagnoli, P., & Herzog, V. (2000). A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. European Journal of Cell Biology, 79, 905–914. (10.1078/0171-9335-00117) / European Journal of Cell Biology by J Hoffmann (2000)
  28. Holsinger, R. M., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002). Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease. Annals of Neurology, 51, 783–786. (10.1002/ana.10208) / Annals of Neurology by RM Holsinger (2002)
  29. Hook, G., Hook, V. Y., & Kindy, M. (2007a). Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer’s disease therapeutics. Biological Chemistry, 388, 979–983. (10.1515/BC.2007.117) / Biological Chemistry by G Hook (2007)
  30. Hook, V., Kindy, M., & Hook, G. (2007b). Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer’s disease. Biological Chemistry, 388, 247–252. / Biological Chemistry by V Hook (2007)
  31. Hook, V. Y., Kindy, M., & Hook, G. (2008). Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. The Journal of Biological Chemistry, 283, 7745–7753. (10.1074/jbc.M708362200) / The Journal of Biological Chemistry by VY Hook (2008)
  32. Hook, V. Y., Kindy, M., Reinheckel, T., Peters, C., & Hook, G. (2009). Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochemical and Biophysical Research Communications, 386, 284–288. (10.1016/j.bbrc.2009.05.131) / Biochemical and Biophysical Research Communications by VY Hook (2009)
  33. Hook, V., Toneff, T., Bogyo, M., Greenbaum, D., Medzihradszky, K. F., Neveu, J., et al. (2005). Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer’s disease. Biological Chemistry, 386, 931–940. (10.1515/BC.2005.108) / Biological Chemistry by V Hook (2005)
  34. Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., et al. (2006). Bace1 modulates myelination in the central and peripheral nervous system. Nature Neuroscience, 9, 1520–1525. (10.1038/nn1797) / Nature Neuroscience by X Hu (2006)
  35. Hunt, C. E., & Turner, A. J. (2009). Cell biology, regulation and inhibition of beta-secretase (BACE-1). FEBS Journal, 276, 1845–1859. (10.1111/j.1742-4658.2009.06929.x) / FEBS Journal by CE Hunt (2009)
  36. Huse, J. T., Liu, K., Pijak, D. S., Carlin, D., Lee, V. M., & Doms, R. W. (2002). Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer’s disease brain. The Journal of Biological Chemistry, 277, 16278–16284. (10.1074/jbc.M111141200) / The Journal of Biological Chemistry by JT Huse (2002)
  37. Hussain, I., Powell, D. J., Howlett, D. R., Chapman, G. A., Gilmour, L., Murdock, P. R., et al. (2000). ASP1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site. Molecular and Cellular Neurosciences, 16, 609–619. (10.1006/mcne.2000.0884) / Molecular and Cellular Neurosciences by I Hussain (2000)
  38. Iacono, D., Markesbery, W. R., Gross, M., Pletnikova, O., Rudow, G., Zandi, P., et al. (2009). The nun study. Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (in press). (10.1212/WNL.0b013e3181b01077)
  39. Iacono, D., O’Brien, R., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Rudow, G., et al. (2008). Neuronal hypertrophy in asymptomatic Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 67, 578–589. (10.1097/NEN.0b013e3181772794) / Journal of Neuropathology and Experimental Neurology by D Iacono (2008)
  40. Ishida, A., Furukawa, K., Keller, J. N., & Mattson, M. P. (1997). Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport, 8, 2133–2137. (10.1097/00001756-199707070-00009) / Neuroreport by A Ishida (1997)
  41. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., et al. (2000). Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nature Medicine, 6, 143–150. (10.1038/72237) / Nature Medicine by N Iwata (2000)
  42. Jo, D. G., Arumugam, T. V., Woo, H. N., Park, J. S., Tang, S. C., Mughal, M., et al. (2008). Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer’s disease. Neurobiology of Aging (in press).
  43. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., et al. (2003). APP processing and synaptic function. Neuron, 37, 925–937. (10.1016/S0896-6273(03)00124-7) / Neuron by F Kamenetz (2003)
  44. Kirfel, G., Borm, B., Rigort, A., & Herzog, V. (2002). The secretory beta-amyloid precursor protein is a motogen for human epidermal keratinocytes. European Journal of Cell Biology, 81, 664–676. (10.1078/0171-9335-00284) / European Journal of Cell Biology by G Kirfel (2002)
  45. Klein, D. M., Felsenstein, K. M., & Brenneman, D. E. (2009). Cathepsins B and L differentially regulate amyloid precursor protein processing. Journal of Pharmacology and Experimental Therapeutics, 328, 813–821. (10.1124/jpet.108.147082) / Journal of Pharmacology and Experimental Therapeutics by DM Klein (2009)
  46. Kobayashi, D., Zeller, M., Cole, T., Buttini, M., McConlogue, L., Sinha, S., et al. (2008). BACE1 gene deletion: impact on behavioral function in a model of Alzheimer’s disease. Neurobiology of Aging, 29, 861–873. (10.1016/j.neurobiolaging.2007.01.002) / Neurobiology of Aging by D Kobayashi (2008)
  47. Kohutek, Z. A., di Pierro, C. G., Redpath, G. T., & Hussaini, I. M. (2009). ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. The Journal of Neuroscience, 29, 4605–4615. (10.1523/JNEUROSCI.5126-08.2009) / The Journal of Neuroscience by ZA Kohutek (2009)
  48. Kurochkin, I. V., & Goto, S. (1994). Alzheimer’s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Letter, 345, 33–37. (10.1016/0014-5793(94)00387-4) / FEBS Letter by IV Kurochkin (1994)
  49. Kwak, Y. D., Brannen, C. L., Qu, T., Kim, H. M., Dong, X., Soba, P., et al. (2006). Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells and Development, 15, 381–389. (10.1089/scd.2006.15.381) / Stem Cells and Development by YD Kwak (2006)
  50. Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., et al. (2005). BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. Journal of Neuroscience, 25, 11693–11709. (10.1523/JNEUROSCI.2766-05.2005) / Journal of Neuroscience by FM Laird (2005)
  51. Lannfelt, L., Basun, H., Wahlund, L. O., Rowe, B. A., & Wagner, S. L. (1995). Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer’s disease. Nature Medicine, 1, 829–832. (10.1038/nm0895-829) / Nature Medicine by L Lannfelt (1995)
  52. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature, 457, 1128–1132. (10.1038/nature07761) / Nature by J Laurén (2009)
  53. Le Gall, S. M., Bobé, P., Reiss, K., Horiuchi, K., Niu, X. D., Lundell, D., et al. (2009). ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Molecular Biology of the Cell, 20, 1785–1794. (10.1091/mbc.e08-11-1135) / Molecular Biology of the Cell by SM Le Gall (2009)
  54. Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., et al. (2005). NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. Journal of Neuroscience, 25, 9367–9377. (10.1523/JNEUROSCI.0849-05.2005) / Journal of Neuroscience by S Lesné (2005)
  55. Lewczuk, P., Kornhuber, J., Vanderstichele, H., Vanmechelen, E., Esselmann, H., Bibl, M., et al. (2008). Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study. Neurobiology of Aging, 29, 812–818. (10.1016/j.neurobiolaging.2006.12.010) / Neurobiology of Aging by P Lewczuk (2008)
  56. Li, H., Wolfe, M. S., & Selkoe, D. J. (2009). Toward structural elucidation of the γ-secretase complex. Structure, 17, 326–334. (10.1016/j.str.2009.01.007) / Structure by H Li (2009)
  57. Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., et al. (2001). Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neuroscience, 4, 231–232. (10.1038/85059) / Nature Neuroscience by Y Luo (2001)
  58. Ma, Q. H., Futagawa, T., Yang, W. L., Jiang, X. D., Zeng, L., Takeda, Y., et al. (2008). A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nature Cell Biology, 10, 283–294. (10.1038/ncb1690) / Nature Cell Biology by QH Ma (2008)
  59. Mattson, M. P. (1997). Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiological Reviews, 77, 1081–1132. (10.1152/physrev.1997.77.4.1081) / Physiological Reviews by MP Mattson (1997)
  60. Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I., & Rydel, R. E. (1993). Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron, 10, 243–254. (10.1016/0896-6273(93)90315-I) / Neuron by MP Mattson (1993)
  61. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. E. (1992). beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience, 12, 376–389. (10.1523/JNEUROSCI.12-02-00376.1992) / Journal of Neuroscience by MP Mattson (1992)
  62. Meziane, H., Dodart, J. C., Mathis, C., Little, S., Clemens, J., Paul, S. M., et al. (1998). Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proceedings of the National Academy of Sciences of the United States of America, 95, 12683–12688. (10.1073/pnas.95.21.12683) / Proceedings of the National Academy of Sciences of the United States of America by H Meziane (1998)
  63. Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E. D., Sun, B., Chen, J., et al. (2006). Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer’s disease. Neuron, 51, 703–714. (10.1016/j.neuron.2006.07.027) / Neuron by S Mueller-Steiner (2006)
  64. Müller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008). The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease. Progress in Neurobiology, 85, 393–406. (10.1016/j.pneurobio.2008.05.002) / Progress in Neurobiology by T Müller (2008)
  65. Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., & Bezprozvanny, I. (2007). Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. Journal of Clinical Investigation, 117, 1230–1239. (10.1172/JCI30447) / Journal of Clinical Investigation by O Nelson (2007)
  66. Nikolaev, A., McLaughlin, T., O’Leary, D. D., & Tessier-Lavigne, M. (2009). APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature, 457, 981–989. (10.1038/nature07767) / Nature by A Nikolaev (2009)
  67. O’Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., et al. (2008). Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron, 60, 988–1009. (10.1016/j.neuron.2008.10.047) / Neuron by T O’Connor (2008)
  68. Oh, E. S., Savonenko, A. V., King, J. F., Fangmark Tucker, S. M., Rudow, G. L., Xu, G., et al. (2009). Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiology of Aging, 30, 1238–1244. (10.1016/j.neurobiolaging.2007.12.024) / Neurobiology of Aging by ES Oh (2009)
  69. Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., et al. (2004). BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron, 41, 27–33. (10.1016/S0896-6273(03)00810-9) / Neuron by M Ohno (2004)
  70. Ohsawa, I., Takamura, C., Morimoto, T., Ishiguro, M., & Kohsaka, S. (1999). Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. European Journal of Neuroscience, 11, 1907–1913. (10.1046/j.1460-9568.1999.00601.x) / European Journal of Neuroscience by I Ohsawa (1999)
  71. Olsson, A., Höglund, K., Sjögren, M., Andreasen, N., Minthon, L., Lannfelt, L., et al. (2003). Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Experimental Neurology, 183, 74–80. (10.1016/S0014-4886(03)00027-X) / Experimental Neurology by A Olsson (2003)
  72. Parkin, E. T., Watt, N. T., Hussain, I., Eckman, E. A., Eckman, C. B., Manson, J. C., et al. (2007). Cellular prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America, 104, 11062–11067. (10.1073/pnas.0609621104) / Proceedings of the National Academy of Sciences of the United States of America by ET Parkin (2007)
  73. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., et al. (2004). A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. Journal of Clinical Investigation, 113, 1456–1464. (10.1172/JCI20864) / Journal of Clinical Investigation by R Postina (2004)
  74. Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A., et al. (2007). The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. Journal of Neuroscience, 27, 7817–7826. (10.1523/JNEUROSCI.1026-07.2007) / Journal of Neuroscience by S Ring (2007)
  75. Riudavets, M. A., Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., Martin, L. J., et al. (2007). Resistance to Alzheimer’s pathology is associated with nuclear hypertrophy in neurons. Neurobiology of Aging, 28, 1484–1492. (10.1016/j.neurobiolaging.2007.05.005) / Neurobiology of Aging by MA Riudavets (2007)
  76. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., et al. (2001). BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer’s disease therapeutics. Human Molecular Genetics, 10, 1317–1324. (10.1093/hmg/10.12.1317) / Human Molecular Genetics by SL Roberds (2001)
  77. Saito, Y., Sano, Y., Vassar, R., Gandy, S., Nakaya, T., Yamamoto, T., et al. (2008). X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain. The Journal of Biological Chemistry, 283, 35763–35771. (10.1074/jbc.M801353200) / The Journal of Biological Chemistry by Y Saito (2008)
  78. Sakurai, T., Kaneko, K., Okuno, M., Wada, K., Kashiyama, T., Shimizu, H., et al. (2008). Membrane microdomain switching: A regulatory mechanism of amyloid precursor protein processing. Journal of Cell Biology, 183, 339–352. (10.1083/jcb.200804075) / Journal of Cell Biology by T Sakurai (2008)
  79. Saura, C. A., Chen, G., Malkani, S., Choi, S. Y., Takahashi, R. H., Zhang, D., et al. (2005). Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. Journal of Neuroscience, 25, 6755–6764. (10.1523/JNEUROSCI.1247-05.2005) / Journal of Neuroscience by CA Saura (2005)
  80. Savonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K. A., Price, D. L., & Wong, P. C. (2008). Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proceedings of the National Academy of Sciences of the United States of America, 105, 5585–5590. (10.1073/pnas.0710373105) / Proceedings of the National Academy of Sciences of the United States of America by AV Savonenko (2008)
  81. Schechter, I., & Ziv, E. (2008). Kinetic properties of cathepsin D and BACE 1 indicate the need to search for additional beta-secretase candidate(s). Biological Chemistry, 389, 313–320. (10.1515/BC.2008.025) / Biological Chemistry by I Schechter (2008)
  82. Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., et al. (2008). Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology. Nature Medicine, 14, 1106–1111. (10.1038/nm.1872) / Nature Medicine by S Schilling (2008)
  83. Selkoe, D. J. (2000). Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Annals of the New York Academy of Sciences, 924, 17–25. (10.1111/j.1749-6632.2000.tb05554.x) / Annals of the New York Academy of Sciences by DJ Selkoe (2000)
  84. Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L. O., Winblad, B., & Benedikz, E. (2000). Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer’s disease patients. Neuroscience Letters, 278, 169–172. (10.1016/S0304-3940(99)00929-5) / Neuroscience Letters by K Sennvik (2000)
  85. Serneels, L., Van Biervliet, J., Craessaerts, K., Dejaegere, T., Horré, K., Van Houtvin, T., et al. (2009). gamma-Secretase heterogeneity in the Aph-1 subunit: Relevance for Alzheimer’s disease. Science, 324, 639–642. (10.1126/science.1171176) / Science by L Serneels (2009)
  86. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., et al. (2008). Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nature Medicine, 14, 837–842. (10.1038/nm1782) / Nature Medicine by GM Shankar (2008)
  87. Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., et al. (2009). Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Annals of Neurology, 65, 403–413. (10.1002/ana.21610) / Annals of Neurology by LM Shaw (2009)
  88. Shimizu, T., Fukuda, H., Murayama, S., Izumiyama, N., & Shirasawa, T. (2002). Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer’s disease. Journal of Neuroscience Research, 70, 451–461. (10.1002/jnr.10350) / Journal of Neuroscience Research by T Shimizu (2002)
  89. Siemes, C., Quast, T., Kummer, C., Wehner, S., Kirfel, G., Müller, U., et al. (2006). Keratinocytes from APP/APLP2-deficient mice are impaired in proliferation, adhesion and migration in vitro. Experimental Cell Research, 312, 1939–1949. (10.1016/j.yexcr.2006.02.025) / Experimental Cell Research by C Siemes (2006)
  90. Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W., & Lee, V. M. (2000). Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. The Journal of Biological Chemistry, 275, 2568–2575. (10.1074/jbc.275.4.2568) / The Journal of Biological Chemistry by DM Skovronsky (2000)
  91. Sun, B., Zhou, Y., Halabisky, B., Lo, I., Cho, S. H., Mueller-Steiner, S., et al. (2008). Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer’s disease. Neuron, 60, 247–257. (10.1016/j.neuron.2008.10.001) / Neuron by B Sun (2008)
  92. Tabuchi, K., Chen, G., Südhof, T. C., & Shen, J. (2009). Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration. Journal of Neuroscience, 29, 7290–7301. (10.1523/JNEUROSCI.1320-09.2009) / Journal of Neuroscience by K Tabuchi (2009)
  93. Tamgüney, G., Giles, K., Glidden, D. V., Lessard, P., Wille, H., Tremblay, P., et al. (2008). Genes contributing to prion pathogenesis. Journal of General Virology, 89, 1777–1788. (10.1099/vir.0.2008/001255-0) / Journal of General Virology by G Tamgüney (2008)
  94. Tanabe, C., Hotoda, N., Sasagawa, N., Sehara-Fujisawa, A., Maruyama, K., & Ishiura, S. (2006). ADAM19 is tightly associated with constitutive Alzheimer’s disease APP alpha-secretase in A172 cells. Biochemical and Biophysical Research Communications, 352, 111–117. (10.1016/j.bbrc.2006.10.181) / Biochemical and Biophysical Research Communications by C Tanabe (2006)
  95. Taylor, C. J., Ireland, D. R., Ballagh, I., Bourne, K., Marechal, N. M., Turner, P. R., et al. (2008). Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiology of Diseases, 31, 250–260. (10.1016/j.nbd.2008.04.011) / Neurobiology of Diseases by CJ Taylor (2008)
  96. Thathiah, A., Spittaels, K., Hoffmann, M., Staes, M., Cohen, A., Horré, K., et al. (2009). The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science, 323, 946–951. (10.1126/science.1160649) / Science by A Thathiah (2009)
  97. Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron, 17, 181–190. (10.1016/S0896-6273(00)80291-3) / Neuron by G Thinakaran (1996)
  98. Thinakaran, G., & Koo, E. H. (2008). Amyloid precursor protein trafficking, processing, and function. The Journal of Biological Chemistry, 283, 29615–29619. (10.1074/jbc.R800019200) / The Journal of Biological Chemistry by G Thinakaran (2008)
  99. Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S. F., Hao, Y. H., et al. (2006). Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell, 126, 981–993. (10.1016/j.cell.2006.06.059) / Cell by H Tu (2006)
  100. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., et al. (1999). β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286, 735–741. (10.1126/science.286.5440.735) / Science by R Vassar (1999)
  101. Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., et al. (2009). Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. The Journal of Biological Chemistry, 284, 3793–3803. (10.1074/jbc.M808920200) / The Journal of Biological Chemistry by KS Vetrivel (2009)
  102. Vogt, D. L., Thomas, D., Galvan, V., Bredesen, D. E., Lamb, B. T. & Pimplikar, S. W. (2009). Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiology of Aging (in press).
  103. Wakabayashi, T., & De Strooper, B. (2008). Presenilins: Members of the gamma-secretase quartets, but part-time soloists too. Physiology, 23, 194–204. (10.1152/physiol.00009.2008) / Physiology by T Wakabayashi (2008)
  104. Waldron, E., Isbert, S., Kern, A., Jaeger, S., Martin, A. M., Hébert, S. S., et al. (2008). Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Experimental Cell Research, 314, 2419–2433. (10.1016/j.yexcr.2008.05.003) / Experimental Cell Research by E Waldron (2008)
  105. Wegiel, J., Kuchna, I., Nowicki, K., Frackowiak, J., Mazur-Kolecka, B., Imaki, H., et al. (2007). Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathologica, 113, 389–402. (10.1007/s00401-006-0191-4) / Acta Neuropathologica by J Wegiel (2007)
  106. Westmeyer, G. G., Willem, M., Lichtenthaler, S. F., Lurman, G., Multhaup, G., Assfalg-Machleidt, I., et al. (2004). Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. The Journal of Biological Chemistry, 279, 53205–53212. (10.1074/jbc.M410378200) / The Journal of Biological Chemistry by GG Westmeyer (2004)
  107. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., et al. (2006). Control of peripheral nerve myelination by the beta-secretase BACE1. Science, 314, 664–666. (10.1126/science.1132341) / Science by M Willem (2006)
  108. Winkler, E., Hobson, S., Fukumori, A., Dümpelfeld, B., Luebbers, T., Baumann, K., et al. (2009). Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase. Biochemistry, 48, 1183–1197. (10.1021/bi801204g) / Biochemistry by E Winkler (2009)
  109. Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., et al. (2001). Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neuroscience Letters, 306, 116–120. (10.1016/S0304-3940(01)01876-6) / Neuroscience Letters by O Wirths (2001)
  110. Wolfe, M. S. (2008). Inhibition and modulation fo γ-secretase for Alzheimer’s disease. Neurotherapeutics, 5, 391–398. (10.1016/j.nurt.2008.05.010) / Neurotherapeutics by MS Wolfe (2008)
  111. Yang, T., Arslanova, D., Gu, Y., Augelli-Szafran, C., & Xia, W. (2008). Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein. Molecular Brain, 1, 1–15. (10.1186/1756-6606-1-15) / Molecular Brain by T Yang (2008)
  112. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., et al. (2003). Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nature Medicine, 9, 3–4. (10.1038/nm0103-3) / Nature Medicine by LB Yang (2003)
  113. Yu, H., Saura, C. A., Choi, S. Y., Sun, L. D., Yang, X., Handler, M., et al. (2001). APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron, 31, 713–726. (10.1016/S0896-6273(01)00417-2) / Neuron by H Yu (2001)
Dates
Type When
Created 15 years, 9 months ago (Nov. 23, 2009, 3:40 a.m.)
Deposited 2 years, 3 months ago (May 27, 2023, 12:55 p.m.)
Indexed 2 days, 20 hours ago (Aug. 30, 2025, 12:35 p.m.)
Issued 15 years, 9 months ago (Nov. 24, 2009)
Published 15 years, 9 months ago (Nov. 24, 2009)
Published Online 15 years, 9 months ago (Nov. 24, 2009)
Published Print 15 years, 6 months ago (March 1, 2010)
Funders 0

None

@article{Chow_2009, title={An Overview of APP Processing Enzymes and Products}, volume={12}, ISSN={1559-1174}, url={http://dx.doi.org/10.1007/s12017-009-8104-z}, DOI={10.1007/s12017-009-8104-z}, number={1}, journal={NeuroMolecular Medicine}, publisher={Springer Science and Business Media LLC}, author={Chow, Vivian W. and Mattson, Mark P. and Wong, Philip C. and Gleichmann, Marc}, year={2009}, month=nov, pages={1–12} }